# FDA Inspection 1204403 - UChicago Medicine AdventHealth La Grange - March 30, 2023

Source: https://www.keypedia.com/records/fda_inspections/uchicago-medicine-adventhealth-la-grange/836a0324-ecc8-47e0-8e0a-ee15df173c3e
Source feed: FDA_Inspections

> FDA Inspection 1204403 for UChicago Medicine AdventHealth La Grange on March 30, 2023. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1204403
- Company Name: UChicago Medicine AdventHealth La Grange
- Inspection Date: 2023-03-30
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1204403 - 2023-03-30](https://www.keypedia.com/records/fda_inspections/uchicago-medicine-adventhealth-la-grange/668cd68d-45d7-4fff-aaa3-7907894c3e38)

Company: https://www.keypedia.com/companies/uchicago-medicine-adventhealth-la-grange/5201128d-8a6b-4d65-a128-561a2bc0a210

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d